NF-1, Nutraceutical Intervention

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 6, 2022

Primary Completion Date

September 2, 2025

Study Completion Date

August 31, 2026

Conditions
Neurofibromatosis 1
Interventions
DIETARY_SUPPLEMENT

curcumin, high phenolic extra virgin olive oil (HP-EVOO)

"identical for all participants with the exception of the curcumin dose level~Dose 1: 1000 mg Curcumin daily dose with 1 capsule of 25 ml HP-EVOO volume at morning and night Dose 1: 2000 mg Curcumin daily dose with 2 capsules of 25 ml HP-EVOO volume at morning and night Dose 3: 4000 mg Curcumin daily dose with 4 capsules of 25 ml HP-EVOO volume at morning and night"

Trial Locations (1)

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

All Listed Sponsors
lead

Masonic Cancer Center, University of Minnesota

OTHER